Clinical Trials Logo

Cesarean Section Pain clinical trials

View clinical trials related to Cesarean Section Pain.

Filter by:
  • None
  • Page 1

NCT ID: NCT05276206 Completed - Post Operative Pain Clinical Trials

Application of Transversus Abdominus Plain Block, Local Subcutaneous Injection and IV Nalbuphine

Start date: March 7, 2022
Phase: Phase 1
Study type: Interventional

Approximately 1 in 5 women who undergo CS will experience severe acute postoperative pain. The severity of pain in the acute postoperative period is a significant predictor for the development of chronic pain, which occurs in 9.2%-18% of women who undergo CS. Furthermore, severe acute post-cesarean pain triples a woman's risk of developing postpartum depression and negatively affects breastfeeding and infant care. For these reasons, it is imperative to provide adequate postoperative analgesia in this patient population

NCT ID: NCT04538391 Completed - Clinical trials for Cesarean Section Pain

Intra Incisional Infiltration of Bupivacaine Versus Meloxicam on Post Cesarean Section Pain Relief

Start date: March 3, 2019
Phase: N/A
Study type: Interventional

Investigation: compare the effect of local infiltration of incision site with bupivacaine and local infiltration with meloxicam in women undergoing cesarean sections on postoperative pain relief and analgesic requirement. Condition: post cesarean sections analgesia intervention: infiltration of incision bupivacaine versus meloxicam Phase: Not applicable

NCT ID: NCT03918187 Completed - Clinical trials for Cesarean Section Pain

Intrathecal Nalbuphine Versus Midazolam in Cesarean Section

Start date: April 10, 2019
Phase: Phase 1
Study type: Interventional

Adequate pain management is important to facilitate the functional recovery and enable the patients for rapid rehabilitation of normal activity . Various adjuvants were being used with intrathecal bupivacain to prolong & improve postoperative pain relief in patients undergoing cesarean section . The aim of this study was to compare intrathecal nalbuphine versus intrathecal midazolam in patient undergoing cesarean section. The investigators primary aims were to compare the characteristics of sensory and motor block, the effective analgesic time, and analgesic requirement. Secondary aims were to compare the side effects, sedation score and apgare score.